Oral Bioavailability and In Vivo Efficacy of the Helicase-Primase Inhibitor BILS 45 BS against Acyclovir-Resistant Herpes Simplex Virus Type 1

類似資料

• Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo
  著者:: Duan, Jianmin, 等
  出版事項: (1998)
• Potent In Vivo Antiviral Activity of the Herpes Simplex Virus Primase-Helicase Inhibitor BAY 57-1293
  著者:: Betz, Ulrich A. K., 等
  出版事項: (2002)
• The three-component helicase/primase complex of herpes simplex virus-1
  著者:: Bermek, Oya, 等
  出版事項: (2021)
• Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection
  著者:: Katsumata, Kiyomitsu, 等
  出版事項: (2013)
• Herpes Simplex Virus Type 1 Helicase-Primase: DNA Binding and Consequent Protein Oligomerization and Primase Activation
  著者:: Chen, Yan, 等
  出版事項: (2011)